0001615774-15-000552.txt : 20150324
0001615774-15-000552.hdr.sgml : 20150324
20150324161924
ACCESSION NUMBER: 0001615774-15-000552
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150320
FILED AS OF DATE: 20150324
DATE AS OF CHANGE: 20150324
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: SECOND SIGHT MEDICAL PRODUCTS INC
CENTRAL INDEX KEY: 0001266806
STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]
IRS NUMBER: 000000000
STATE OF INCORPORATION: CA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 12744 SAN FERNANDO ROAD, BLDG. 3
CITY: SYLMAR
STATE: CA
ZIP: 91342
BUSINESS PHONE: 818-833-5000
MAIL ADDRESS:
STREET 1: 12744 SAN FERNANDO ROAD, BLDG. 3
CITY: SYLMAR
STATE: CA
ZIP: 91342
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Greenberg Robert J.
CENTRAL INDEX KEY: 0001625594
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36747
FILM NUMBER: 15721963
MAIL ADDRESS:
STREET 1: 12744 SAN FERNANDO ROAD, BLDG. 3
CITY: SYLMAR
STATE: CA
ZIP: 91342
4
1
s100905.xml
FORM 4
X0306
4
2015-03-20
0
0001266806
SECOND SIGHT MEDICAL PRODUCTS INC
EYES
0001625594
Greenberg Robert J.
12744 SAN FERNANDO ROAD, BLDG. 3
SYLMAR
CA
91342
1
1
0
0
CHIEF EXECUTIVE OFFICER
COMMON STOCK
2015-03-20
4
S
0
98742
13.28
D
224922
D
COMMON STOCK
2015-03-23
4
S
0
1258
13.40
D
223664
D
Option(b)
4.25
2017-01-01
Common Stock
125000
125000
D
Option(c)
4.75
2015-09-01
Common Stock
150000
150000
D
Option(d)
4.75
2016-01-01
Common Stock
17969
17969
D
Option(e)
5.00
2016-05-01
Common Stock
8223
8223
D
Option(f)
5.00
2017-01-01
Common Stock
30625
30625
D
Option(g)
5.00
2018-02-01
Common Stock
23750
23750
D
Option(h)
5.00
2018-11-01
Common Stock
150000
150000
D
Option(i)
5.00
2019-02-01
Common Stock
23750
23750
D
Option(j)
5.00
2020-02-01
Common Stock
53125
53125
D
Option(k)
5.00
2020-02-01
Common Stock
50625
50625
D
Option(l)
5.00
2021-03-01
Common Stock
41563
41563
D
Option(m)
5.00
2022-03-01
Common Stock
29063
29063
D
Option(n)
5.00
2024-04-01
Common Stock
11718
11718
D
The price reported in Column 4 is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $13.01 to $13.95, inclusive. The reporting person undertakes to provide to the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. These transactions were effected pursuant to planned sales under lock-up agreement entered into at the time of EYES IPO in November 2014, as approved by Board of EYES and the IPO underwriter.
The price reported in Column 4 is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $13.37 to $13.52 inclusive. The reporting person undertakes to provide to the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. These transactions were effected pursuant to planned sales under lock-up agreement entered into at the time of EYES IPO in November 2014, as approved by Board of EYES and the IPO underwriter.
These are vested employee options currently exercisable.
These options will vest and become exercisable within the next 60 days
Excludes unvested employee options in amount of 459,503 shares, which are not exercisable for more than 60 days from this date.
/s/ Robert J. Greenberg
2015-03-24